A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D; Semapimod-CD04/CD05 Investigators.
Dotan I, et al. Among authors: plasse t.
Gut. 2010 Jun;59(6):760-6. doi: 10.1136/gut.2009.179994.
Gut. 2010.
PMID: 20551461
Clinical Trial.